Objectives: To define the prevalence of PHP in patients with RA. Methods: All RA patients who were registered in the local part of Danish Danbio registry were included in this study. Patients'demographic data and serology results (rheumatoid factor (RF) and anti-cyclic citrullinated peptide antibody (anticcp)) were extracted from Danbio. Patients' electronic hospital records including laboratory results (Parathyroid hormone (PTH) and calcium levels) were reviewed to reveal if they had been diagnosed with PHP as well.
the mean disease duration was 11,0 (7,7) years. Of patients, 166 (16,6%) were older than 65 years. A total of 630 (63%) patients education level were less than high school, 197 (19,7%) of the patients were graduated from university. Smoking habitus of patients was as follows, 599 (59,9%) never smoked, 189 (18,9%) current smoker and 212 (21,2%) ex-smoker. At least one cardiovascular risk factor was detected in 699 (69,9%) patients. Comorbidities and surgical history of patients were shown in the table below. Patients with at least one comorbidity had less frequently female (77.3% vs 84.5%, p=0.007), high seropositivitly of RF (66% vs 57.1%, p=0.004), high patient global assessment (4.4±2.5 vs 3.9±3.9, p=0.007), high fatique score (4.6±3 vs 3.9±3.1, p=0.001), high pain score (4.8±2.5 vs 4.0±2.8, p=0.009), p=0, 009) Background: Patients with rheumatoid arthritis (RA) have a higher risk to develop cardiovascular complications than general population (1), leading to a decrease in life expectancy of 3 to 10 years (2). RA is associated to increased left ventricle mass, pericardial effusion and diastolic dysfunction (3). Objectives: The aim of this study was to assess the structure and function of the left ventricle in patients with RA and compare the results with matched controls. Methods: We designed an observational cross-section case-control study. Patients diagnosed with RA according to the 1987 ACR and/or 2010 ACR/EULAR classification criteria, 40-75 years old, with no overlap syndromes, atherosclerotic cardiovascular disease or hypertension were included. Subjects for the control group were matched by sex, age and comorbidities. A board-certified cardiologist performed a transthoracic echocardiogram. Results: We included a total of 44 RA-patients and 26 control subjects. Table  1 summarizes the demographic characteristics for each group. Left ventricular concentric remodeling (LVCR), defined as a relative wall thickness (RWT) >0.42 cm and a left ventricular mass index (LVMI) ≤95 gm/m 2 in women and ≤115 gm/m 2 in men, was found in 14 patients (32.6%) of the RA-group and 2 subjects (8%) of the control group; this difference was statistically significant (p=0.021). When we analyzed general abnormalities of left ventricle (either LVCR or left ventricular concentric hypertrophy [RWT >0.42 cm and LVMI >95 gm/m 2 in women, >115 gm/m 2 in men]) we found 15 RA patients (34.1%) with abnormalities and 3 subjects in the control group (11.5%) (p=0.037). There were no statistically significant differences among the groups in LVMI, diastolic dysfunction, global longitudinal strain or ejection fraction. 
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Background: Neutropenia is an uncommon finding in the context of rheumatoid arthritis (RA). The incidence and association with RA features is not yet well-defined. Objectives: To determine the incidence and severity of neutropenia in an early RA inception cohort, explore possible association with RA features and describe its impact on patient's management. Methods: The Scottish Early Rheumatoid Arthritis (SERA) inception cohort prospectively recruited newly diagnosed RA patients (ACR-EULAR 2010 criteria), who were followed-up every 6 months. Patients who developed at least one episode of neutropenia (grade 1: <2000/μL, grade 2: <1500/μL, grade 3: <1000/μL, grade 4: <500/μL) were compared with patients who never developed neutropenia. Binominal logistic regression was performed, exploiting the enter model and using the occurrence of neutropenia as dependent variable. Results: 77 episodes of neutropenia were observed in 60 (8.6%) out of 698 RA patients, who were followed up for a median (range) time of 18 (6-48) months. Neutropenia occured in 12 (0-120) [median (range)] months after RA diagnosis. The majority had mild neutropenia (grade 1: n=49, grade 2: n=9, grade 3: n=0, grade 4: n=2) and the mean ± SD number of neutrophils/μL was 1.68±0.35. Of the 77 neutropenic episodes recorded, coexistent lymphopenia was found in 13.0%, leukopenia in 70.1%, thrombocytopenia in 1.3% and anaemia in 32.5%. At the time of the neutropenia, most of the patients were in remission (DAS28<2.6: 53%, DAS28<3.2: 15.5%, DAS28≤5.1: 22.4%, DAS28>5.1: 8.6%). Neutropenia was a single episode in the majority (76.7%) of the patients and led to treatment discontinuation in 11.7% of them. Patients who subsequently developed neutropenia, were more likely females (p=0.03) and non-smokers (p=0.0009) ( 
